Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia

scientific article published on June 2009

Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2362.2009.02131.X
P932PMC publication ID3709071
P698PubMed publication ID19490058

P50authorChristine MannhalterQ21013476
Christoph SteiningerQ44099944
Katrina VanuraQ63644182
P2093author name stringS Stilgenbauer
U Jäger
L Z Rassenti
T J Kipps
K Eigenberger
T Popow-Kraupp
P2860cites workGuidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesQ24616084
Seroepidemiology of human herpesvirus 6 infection in normal children and adultsQ24653998
Chronic lymphocytic leukemiaQ28236621
Seroprevalence of cytomegalovirus infection in the United States, 1988-1994Q28267544
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international studyQ33342242
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemiaQ33368885
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cellsQ33853435
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatmentQ34382878
National serosurvey of cytomegalovirus in AustraliaQ35160692
Respiratory tract infections and subsequent risk of chronic lymphocytic leukemiaQ35642807
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.Q36491858
Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemiaQ36564936
Heterosexual and homosexual patients with the acquired immunodeficiency syndrome. A comparison of surveillance, interview, and laboratory dataQ36598349
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemiaQ36843749
Prevalence of Epstein-Barr virus in Japan: trends and future predictionQ38438737
Comparison of seroprevalences of human herpesvirus-6 and -7 in healthy blood donors from nine countriesQ39149186
A prospective survey of human herpesvirus-6 primary infection in solid organ transplant recipients.Q40467555
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.Q40481231
Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1.Q41285359
Human cytomegalovirus glycoproteinsQ41454511
Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunityQ41813050
Seroepidemiology of human herpesvirus-6 in pregnant women from different parts of the worldQ43936326
Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genesQ44099875
Seropositivity of Epstein-Barr virus in Eastern Anatolian Region of Turkey.Q45722142
Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients.Q46020114
Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activationQ46344878
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabineQ46508260
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemiaQ46913558
Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist.Q48009213
Prevalence and avidity of human herpesvirus-6 specific IgG antibodies in pregnant women in Hungary.Q51805615
Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens.Q51962180
Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.Q54498587
Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 geneQ58041642
The Dynamics of Herpesvirus and Polyomavirus Reactivation and Shedding in Healthy Adults: A 14‐Month Longitudinal StudyQ61911882
The seroepidemiology of human herpesvirus-6 (HHV-6) from a case-control study of leukaemia and lymphomaQ68458532
Leukemias, myeloma, and other lymphoreticular neoplasmsQ71987801
Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-upQ72401901
Reactivation and shedding of cytomegalovirus in astronauts during spaceflightQ73166629
Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and WalesQ74457022
Antibody maturation and viremia after primary cytomegalovirus infection, in immunocompetent patients and kidney-transplant patientsQ80969616
P433issue6
P921main subjectseroprevalenceQ3511357
lymphocyteQ715347
leukemiaQ29496
P304page(s)497-506
P577publication date2009-06-01
P1433published inEuropean Journal of Clinical InvestigationQ15745208
P1476titleRelative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia
P478volume39

Reverse relations

cites work (P2860)
Q93047773Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Q34055555EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL
Q61796918Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLL
Q50882779Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
Q59808635Human Herpesvirus 6 and Malignancy: A Review
Q42323395Immunoglobulin gene repertoire in chronic lymphocytic leukemia: insight into antigen selection and microenvironmental interactions
Q54213118Lymphoproliferative Syndromes Associated with Human Herpesvirus-6A and Human Herpesvirus-6B.
Q36670209Mechanistic insights into the impairment of memory B cells and antibody production in the elderly
Q40044803Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens
Q35849244Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen
Q45369793Serological detection of Epstein-Barr virus infection in dogs and cats
Q50654687Specific cytotoxic T-cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells.
Q35667788Study of the Associations Between TT Virus Single and Mixed Infections With Leukemia
Q27025715The pathogenesis of chronic lymphocytic leukemia
Q35560251β-HHVs and HHV-8 in Lymphoproliferative Disorders.